Navigation Links
SINOL USA, Inc. and Strategic Pharmaceutical Advisors, Inc. to Enter a Marketing Agreement for SINOL Nasal Spray
Date:7/1/2008

Strategic Pharmaceutical Advisors (SRxA) and Sinol USA, Inc. announced the signing of a Memorandum of Understanding signifying their intent to enter into a marketing agreement for SINOL Nasal Spray, an all natural, capsaicin-based product for fast relief from allergy and sinus congestion and headaches of all types.

Washington, DC, and Newtown, CT (PRWEB) July 1, 2008 -- Strategic Pharmaceutical Advisors (SRxA) and Sinol USA, Inc., announced today the signing of a Memorandum of Understanding signifying their intent to enter into a marketing agreement for SINOL Nasal Spray. Under the proposed terms of the agreement SRxA will lead the worldwide educational and information support of SINOL Nasal Spray to professional and consumer audiences.

Headquartered in Newtown Connecticut, Sinol USA Inc. is a healthcare company dedicated to the Development of products using all natural ingredients. Available without a prescription, SINOL Nasal Spray formulations use clean, old fashioned ingredients for fast relief from allergy and sinus congestion and headaches of all degrees and types.

SRxA is a health education and strategic planning firm with world-renowned physicians as its partners and advisors. As part of this agreement, SRxA will develop programming tailored to the education of professional and consumer audiences and deliver it in a variety of media appropriate for each target audiences. Strategic Pharmaceutical Advisors is headquartered in Washington, DC, with offices in London and Hong Kong.

In announcing this collaboration, Paul Carpenter, Chief Executive Officer of Sinol USA, Inc. noted, "SINOL Nasal Sprays have caught the attention of U.S. medical practitioners in a very short period of time. With this collaboration, we now look forward to expanding our US base and reaching an international physician audience through the proven expertise and global sphere of influence of Strategic Pharmaceutical Advisors."

Dr. Christos S. Efessiou, Strategic Pharmaceutical Advisors' Chief Executive Officer, commented "The option of providing the public with an all natural, non-prescription alternative for relief from allergy-related congestion and headaches, impressed our Team enough to seek an active partnership in SINOL. My colleagues and I are excited at the possibilities that this partnership will offer to healthcare professionals and to allergy and headache sufferers."

Sinol USA is presently working with Strategic BioSciences, a SRxA affiliate, in a pioneering new product reformulation agreement which is expected to offer significant advantages to SINOL users. The two companies expect to announce this agreement in the near future.

For more information please visit: www.SRxA.com and www.sinolusa.com.

# # #


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
2. Honour Healthcare and River Logic Deliver Comprehensive Integrated Business Planning Solution Through Strategic Alliance
3. American Well and Microsoft Enter Into a Strategic Collaboration to Bring Healthcare to Peoples Homes
4. StayWell Custom Communications Announces Strategic Alliance With HealthMedia
5. TetraQ and Q-Pharm form strategic alliance
6. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
7. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
8. Nonin(R) Medical Announces Strategic Relationship With Microsoft and its Microsoft HealthVault Platform
9. Xceed Molecular Licenses Signature from Moffitt Cancer Center and Adds Moffitt to Strategic Collaborator Program
10. Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
11. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... to host the 2021 World Cancer Leaders’ Summit in Boston, MA, in October ... brings together key decision makers including prime ministers, ministers of health, city and ...
(Date:2/20/2020)... (PRWEB) , ... February 20, 2020 , ... Millennial women ... Surgery & Laser Center in Milford, Penn requesting treatments to achieve “ Rich Girl ... it doesn’t look like it is slowing down into 2020. It’s a look inspired ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... of and application deadline for its new Lifestyle Medicine Residency Curriculum (LMRC). The ... integrated implementation into medical residency programs. Driven by resident involvement, the curriculum ...
(Date:2/19/2020)... NEEDHAM, Mass. (PRWEB) , ... February 19, 2020 ... ... improve the quality and consistency of healthcare delivery, announced that it will participate ... 13, 2020, in Orlando, Florida. BPM+ Health will engage healthcare professionals and other ...
(Date:2/16/2020)... ... 16, 2020 , ... Accumen Inc., the leader in healthcare ... The Joint Commission to provide a complimentary series of Patient Blood Management (PBM) ... transfusion safety officers) within U.S. hospitals. , “Accumen’s mission is to ...
Breaking Medicine News(10 mins):
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Mario Canal and Ben ... 20, 2020 at The Mansion in Voorhees. The course features guest speaker, Dr. Amanda ... implants. Dental implants, including All-on-4® full mouth dental implants, are a ...
(Date:2/19/2020)... , ... February 19, 2020 ... ... notebook platform for research data management, has released a new SnapGene ... data management features. With a ‘Quick View’ of supported DNA files, the ...
(Date:2/19/2020)... ... February 19, 2020 , ... The swine flu (H1N1) was the virus that ... a potential new outbreak. Although the U.S. has eradicated this disease after its ... countries in the world, posing a risk from trading partners. , In a ...
Breaking Medicine Technology: